| Gholam Jabbari, MD | |
|
2104 Cedarwood Dr, Ste 200, Muscatine, IA 52761-2659 | |
| (563) 263-4848 | |
| (563) 263-3332 |
| Full Name | Gholam Jabbari |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 2104 Cedarwood Dr, Muscatine, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801867957 | NPI | - | NPPES |
| 3182618 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 22437 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gholam Jabbari, MD 2104 Cedarwood Dr, Ste 200, Muscatine, IA 52761-2659 Ph: (563) 263-4848 | Gholam Jabbari, MD 2104 Cedarwood Dr, Ste 200, Muscatine, IA 52761-2659 Ph: (563) 263-4848 |
News Archive
The New York Times profiles physician, professor and author Dr. Abraham Verghese: "At Stanford, he is on a mission to bring back something he considers a lost art: the physical exam. The old-fashioned touching, looking and listening — the once prized, almost magical skills of the doctor who missed nothing and could swiftly diagnose a peculiar walk, sluggish thyroid or leaky heart valve using just keen eyes, practiced hands and a stethoscope.
The British government has set out plans to address all the issues that affect people with mental health problems rather than just focusing on their medical needs. It has also called for a major shift in attitudes towards people with mental health problems.
MEDIAN Technologies (ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, announced today it has been selected as the imaging solutions and services provider in a new phase II clinical trial on Non Small Cell Lung Cancer (NSCLC).
Shire plc, the global specialty biopharmaceutical company, today announced that data from one of three Phase III clinical trials for velaglucerase alfa, the company's enzyme replacement therapy (ERT) in development for the treatment of Type 1 Gaucher disease, will be presented at the Lysosomal Disease Network (LDN) World Symposium, February 10-12, 2010 in Miami, Florida.
› Verified 1 days ago
Susan Bettina Coleman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1518 Mulberry Ave, Muscatine, IA 52761 Phone: 563-264-9424 Fax: 563-264-9195 |